Trial intelligence / Profile preview

Eszopiclone for PTSD

NCT01605253Phase 4Completed

Sponsor
Rush University Medical Center
Start
Mar 2012
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of eszopiclone in post-traumatic stress disorder (PTSD), sponsored by Rush University Medical Center. Started Mar 2012; status: completed.

02

Drugs

eszopiclone
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT01605253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01605253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call